Literature DB >> 3059679

Expression of the Moloney murine leukemia virus and human immunodeficiency virus integration proteins in Escherichia coli.

A Hizi1, S H Hughes.   

Abstract

We have constructed expression plasmids containing the genes for the MuLV and the HIV integration proteins. When introduced into Escherichia coli, these plasmids cause the production of proteins of the expected molecular weight (43K for MuLV, 31K for HIV). The wild-type MuLV coding region induces the synthesis of large amounts of integration protein; to obtain large amounts of the full-length HIV integration protein in E. coli, it was necessary to modify the coding region to disrupt a sequence that promotes efficient internal translational initiation in E. coli. It is possible to disrupt this sequence without altering the encoded amino acids; the modified plasmid makes large amounts of the full-length protein and small amounts of the internally initiated protein. Both the MuLV and HIV integration proteins require SDS to be solubilized in E. coli extracts; however, following solubilization with SDS and transfer to a nitrocellulose filter, both integration proteins bind DNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3059679

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  HIV-1 integrase blocks infection of bacteria by single-stranded DNA and RNA bacteriophages.

Authors:  R Levitz; K Drlica; E Murphy
Journal:  Mol Gen Genet       Date:  1994-05-25

3.  Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis.

Authors:  A M Woerner; C J Marcus-Sekura
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

4.  Expression of a processed and a non-processed form of the integrase protein of HIV-1 in the baculovirus system.

Authors:  B Rodner; C Vinga-Martins; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.

Authors:  A Engelman; A B Hickman; R Craigie
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Detection and characterization of a functional complex of human immunodeficiency virus type 1 integrase and its DNA substrate by UV cross-linking.

Authors:  T Yoshinaga; Y Kimura-Ohtani; T Fujiwara
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  The protease and reverse transcriptase of the tobacco LTR retrotransposon Tnt1 are enzymatically active when expressed in Escherichia coli.

Authors:  F Feuerbach; H Lucas
Journal:  Plant Mol Biol       Date:  2001-07       Impact factor: 4.076

8.  Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions.

Authors:  E V Barsov; W E Huber; J Marcotrigiano; P K Clark; A D Clark; E Arnold; S H Hughes
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Immunological characterization of the gag gene products of bovine immunodeficiency virus.

Authors:  J K Battles; M Y Hu; L Rasmussen; G J Tobin; M A Gonda
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2.

Authors:  D C van Gent; Y Elgersma; M W Bolk; C Vink; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.